T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
E
|
ECO Animal Health Group PLC
LSE:EAH
|
UK |
|
Moringa Acquisition Corp
NASDAQ:MACA
|
US |
|
Roolife Group Ltd
ASX:RLG
|
AU |
|
M
|
micromobility.com inc
OTC:MCOM
|
US |
|
T
|
Twim Corp
KOSDAQ:290090
|
KR |
|
T
|
Talenthouse AG
SIX:THAG
|
CH |
|
MTN Group Ltd
OTC:MTNOF
|
ZA |
|
T
|
Thurgauer Kantonalbank
SIX:TKBP
|
CH |
|
E
|
Eldorado Gold Corp
SWB:ELO1
|
CA |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
St Dupont SA
PAR:DPT
|
FR |
Wall Street
Price Targets
TMAN Price Targets Summary
T Man Pharmaceutical PCL
According to Wall Street analysts, the average 1-year price target for TMAN is 18.16 THB with a low forecast of 17.98 THB and a high forecast of 18.69 THB.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TMAN's stock price target?
Price Target
18.16
THB
According to Wall Street analysts, the average 1-year price target for TMAN is 18.16 THB with a low forecast of 17.98 THB and a high forecast of 18.69 THB.
What is T Man Pharmaceutical PCL's Revenue forecast?
Projected CAGR
12%
For the last 2 years the compound annual growth rate for T Man Pharmaceutical PCL's revenue is 13%. The projected CAGR for the next 2 years is 12%.
What is T Man Pharmaceutical PCL's Operating Income forecast?
Projected CAGR
8%
For the last 2 years the compound annual growth rate for T Man Pharmaceutical PCL's operating income is 11%. The projected CAGR for the next 2 years is 8%.
What is T Man Pharmaceutical PCL's Net Income forecast?
Projected CAGR
2%
For the last 2 years the compound annual growth rate for T Man Pharmaceutical PCL's net income is 10%. The projected CAGR for the next 2 years is 2%.
